Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • COVID-19 impact
  • IPSRH: Focus on Abortion
  • Adding It Up
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Asia
  • Latin America & the Caribbean
  • Sub-Saharan Africa
  • United States

Who We Are

  • About us
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Guttmacher Guardians
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • COVID-19 impact
  • IPSRH: Focus on Abortion
  • Adding It Up
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Asia
  • Latin America & the Caribbean
  • Sub-Saharan Africa
  • United States

Who We Are

  • About us
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Guttmacher Guardians
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship

Search form

Global

HIV & STIs

The Guttmacher Institute’s international work on HIV and other STIs focuses on developing regions. Our research and advocacy efforts have focused on the linkages between HIV and sexual and reproductive health and rights, the impact of STIs on maternal and newborn health, the need for new technologies (including multipurpose prevention technologies) and U.S. support for global AIDS programs. 

  • Fact Sheet

    Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

  • Policy Analysis

    The COVID-19 Outbreak: Potential Fallout for Sexual and Reproductive Health and Rights

  • Policy Analysis

    Just $10 Per Person a Year Could Provide Sexual and Reproductive Health Services to All—Will the United States Help Make That Happen?

Top Facts & Statistics

  • 6.6M

    women in developing regions have an unmet need for antiretroviral therapy
  • $1.00

    the annual per capita cost to meet the need for essential adolescent sexual and reproductive health services
  • 1 in 3

    pregnant women in the developing world living with HIV receive no antiretroviral medication

Resources

  • July 2020 News Release

    La fourniture de soins essentiels de santé sexuelle et reproductive réduirait d’environ deux tiers les grossesses non planifiées, les avortements non médicalisés et la mortalité maternelle

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 Fact Sheet

    Invertir en salud sexual y reproductiva en países de ingreso bajo y mediano

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 News Release

    Provision of Essential Sexual and Reproductive Health Care Would Reduce Unintended Pregnancies, Unsafe Abortions and Maternal Deaths by About Two-Thirds

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 Fact Sheet

    Investir dans la santé sexuelle et reproductive des adolescentes dans les pays à revenu faible ou intermédiaire

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 Report

    Haciendo cuentas: invertir en salud sexual y reproductiva 2019—Resumen ejecutivo

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • June 2020 Research Article

    Budgeting for comprehensive sexual and reproductive health and rights under universal health coverage

    Naomi Lince-Deroche, Elizabeth Sully, Lauren Firestein and Taylor Riley,Sexual and Reproductive Health Matters

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • April 2020 Research Article

    Estimates of the Potential Impact of the COVID-19 Pandemic on Sexual and Reproductive Health in Low- and Middle-Income Countries

    Taylor Riley, Elizabeth Sully, Zara Ahmed and Ann Biddlecom,International Perspectives on Sexual and Reproductive Health

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • November 2019 Policy Analysis

    The Integration of Family Planning and HIV Services: Fulfilling Our Promises to Young Women

    Zara Ahmed

    Global

    • HIV & STIs
    • Teens
  • September 2019 Blog / Letter / Op-ed

    World Contraception Day: Celebrating Progress and Maintaining Momentum

    Heather D. Boonstra and Leah H. Keller,IMPT Blog

    Global

    • Contraception
    • HIV & STIs
  • December 2018 Policy Analysis

    What Congress Can Do to Restore U.S. Leadership on Global Sexual and Reproductive Health and Rights

    Jesseca Boyer,Guttmacher Policy Review

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
Explore the Data Center

Hear From An Expert

Several studies have suggested that progestin-only injectable contraceptives (particularly DMPA), may potentially increase women’s risk of HIV acquisition, but overall, the evidence is mixed and difficult to interpret. In collaboration with the World Health Organization, the Centers for Disease Control, and other partners, Guttmacher is leading an effort to systematically collect, assess and synthesize the epidemiological evidence on this important subject, to help ensure that global contraceptive guidance is informed by high-quality, up-to-date scientific information. Providing accurate information about the risks and benefits of various contraceptive options is critical, and empowers people to make more informed family planning decisions

Chelsea Polis

Principal Research Scientist

View sexual and reproductive health research and analysis in your location

THE TIME IS NOW

Stand up for sexual and reproductive health and rights.
We need your support.

Donate
Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2021 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates